Developer docs
API playgroundTry for free, no card

Search company profiles

Excedrin

Full company profile

uuid002dgj6

Namestring
Excedrin
Legal namestring
Excedrin (Brand of Haleon group of companies)
Websiteurl
excedrin.com
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Excedrin operates a consumer-OTC go-to-market model: products are sold as one-time, non-recurring purchases through US mass-retail, drug-store, and e-commerce channels with no prescription required, supported by an FSA/HSA-eligibility message, coupon and Haleon Huddle loyalty programs, and a content-marketing stack (Pain Relief Quiz, Headache & Migraine Academy, You + Excedrin lifestyle hub). Revenue is transactional rather than subscription-based, with end customers split across three primary use-case segments — migraine sufferers, tension/general headache sufferers, and women experiencing hormonal migraines — and the brand is wholly owned by Haleon plc (spun out of GSK in 2022), which provides manufacturing scale, retail negotiating leverage, and cross-brand marketing infrastructure. Specific pricing and brand-level revenue are not publicly disclosed.

Short descriptiontext

Excedrin is a US OTC pharmaceutical brand (owned by Haleon) that sells a family of acetaminophen/aspirin/caffeine combination headache and migraine products, including the #1 neurologist-recommended OTC migraine treatment, via mass retail and e-commerce channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWarren, United States
HQ citystring
Warren
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
OTC headache relief, migraine medication, pain reliever caplets, consumer healthcare, combination analgesic
Industry2 codes
PRIMARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
Product category
OTC Headache and Migraine Medication
Social media profiles4 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1OTC Consumer Health Product Sales
TypeOne Time License
Description

Excedrin generates revenue through the sale of over-the-counter headache and migraine relief medications. Products are sold as one-time purchases through retail pharmacies, mass retailers, and e-commerce channels. Revenue is transactional rather than recurring, with typical consumer purchase patterns of occasional use for headache relief.

excedrin.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Excedrin Extra Strength
Description

Over-the-counter headache relief caplets for minor aches and pain

excedrin.com
+4 more records
Core offering1 text field

Excedrin manufactures and sells a family of over-the-counter headache and migraine relief medications combining acetaminophen, aspirin, and caffeine. The product line includes Extra Strength, Migraine, Tension Headache, PM Headache, and Rapid Relief variants sold to U.S. consumers through retail pharmacies, drug stores, mass merchants, and e-commerce channels without a prescription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Excedrin Rapid Relief starts working in 15 minutes
+2 more records
Product overview1 text field

Excedrin is a family of over-the-counter headache and migraine relief products manufactured by Haleon (formerly part of GlaxoSmithKline). The product line includes Excedrin Extra Strength (the original multi-ingredient formulation from 1960), Excedrin Migraine (FDA-approved and #1 neurologist recommended, introduced 1998), Excedrin PM (nighttime formula with sleep aid, introduced 1969), Excedrin Tension Headache, and the newer Excedrin Rapid Relief featuring patented fast-release technology. All products combine acetaminophen, aspirin, and caffeine for dual-action pain relief that works faster than ibuprofen for head pain.

Product and service5 records
1Excedrin Extra Strength
CategoryOTC headache relief
Description

Over-the-counter headache relief caplets containing acetaminophen, aspirin, and caffeine; the first multi-ingredient headache treatment product on the market, introduced in 1960.

2Excedrin Migraine
CategoryOTC migraine medication
Description

FDA-approved over-the-counter migraine treatment containing acetaminophen, aspirin, and caffeine; the #1 neurologist-recommended OTC migraine medicine and the first migraine medication available without a prescription, introduced in 1998.

3Excedrin PM Headache
CategoryOTC nighttime headache relief
Description

Nighttime headache relief combining effective pain relievers with a sleep aid; the first combination head pain and sleep aid product, introduced in 1969.

4Excedrin Tension Headache
CategoryOTC tension headache relief
Description

Over-the-counter tension headache relief product designed to temporarily relieve minor aches and pain due to headache and muscular aches.

5Excedrin Rapid Relief
CategoryOTC fast-acting headache relief
Description

OTC headache product featuring patented fast-release technology that delivers pain relief starting in 15 minutes; targets tough head pain with quick onset.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Nurtec ODT
TypeEmerging player
Description

Pfizer/Biohaven's prescription CGRP migraine drug now also available OTC for acute migraine. Represents the prescription-to-OTC shift that could either complement or cannibalize Excedrin Migraine depending on regulatory and pricing outcomes.

TypeDirect peer
Description

Haleon's sister ibuprofen brand and a direct OTC pain reliever competitor. Despite the shared Haleon parent, Advil competes head-to-head with Excedrin on the same retail shelves for the same headache and pain use cases.

3BC Powder
TypeDirect peer
Description

OTC headache powder brand (Chattem/Sanofi) historically positioned for fast headache relief. BC Powder is a direct competitor to Excedrin in the speed-of-onset OTC segment.

4Aleve
TypeDirect peer
Description

Bayer's naproxen-based OTC pain reliever. Aleve competes directly with Excedrin on long-lasting headache relief, offering a 12-hour dosing alternative to Excedrin's short-acting combination formula.

TypeDirect peer
Description

Johnson & Johnson's flagship OTC analgesic brand. Tylenol is Excedrin's most direct competitor in OTC headache and pain relief, targeting the same consumer segments with acetaminophen-based formulations.

6Anacin
TypeDirect peer
Description

OTC analgesic combining aspirin and caffeine — a formula very close to Excedrin's core combination. Anacin competes directly with Excedrin Extra Strength in the same combination-analgesic sub-category.

7Midol
TypeEmerging player
Description

Bayer's OTC brand for menstrual and hormonal-related pain, including menstrual migraines. Midol overlaps with Excedrin's 'women's hormonal migraine' customer segment, addressing the same 3-in-4 female migraine-sufferer persona.

TypeBroad incumbent
Description

Bayer's flagship OTC pain reliever and a 100+ year heritage brand. Bayer Aspirin competes with Excedrin on the aspirin-based portion of Excedrin's combination formula and shares headache-relief shelf space.

TypeDirect peer
Description

Johnson & Johnson's ibuprofen-based OTC pain brand. Motrin is a direct substitute for Excedrin's Extra Strength and Tension Headache SKUs, competing on speed of relief claims.

TypeDirect peer
Description

Chattem/Sanofi's OTC headache powder containing acetaminophen, aspirin, and caffeine — a formula identical to Excedrin Extra Strength. Direct head-to-head competitor in the combination-analgesic segment.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Excedrin

OTC Headache and Migraine Medicationexcedrin.com

Excedrin is a US OTC pharmaceutical brand (owned by Haleon) that sells a family of acetaminophen/aspirin/caffeine combination headache and migraine products, including the #1 neurologist-recommended OTC migraine treatment, via mass retail and e-commerce channels.

What Excedrin does

Excedrin operates a consumer-OTC go-to-market model: products are sold as one-time, non-recurring purchases through US mass-retail, drug-store, and e-commerce channels with no prescription required, supported by an FSA/HSA-eligibility message, coupon and Haleon Huddle loyalty programs, and a content-marketing stack (Pain Relief Quiz, Headache & Migraine Academy, You + Excedrin lifestyle hub). Revenue is transactional rather than subscription-based, with end customers split across three primary use-case segments — migraine sufferers, tension/general headache sufferers, and women experiencing hormonal migraines — and the brand is wholly owned by Haleon plc (spun out of GSK in 2022), which provides manufacturing scale, retail negotiating leverage, and cross-brand marketing infrastructure. Specific pricing and brand-level revenue are not publicly disclosed.

Excedrin firmographics

Firmographics
Name
Excedrin
Legal name
Excedrin (Brand of Haleon group of companies)
Website
https://excedrin.com
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
11–50 employees
Short description
Excedrin is a US OTC pharmaceutical brand (owned by Haleon) that sells a family of acetaminophen/aspirin/caffeine combination headache and migraine products, including the #1 neurologist-recommended OTC migraine treatment, via mass retail and e-commerce channels.
Ownership category
akta.pro rank

Excedrin industry classification

Industry
Product category
OTC Headache and Migraine Medication
NAICS
Pharmaceutical Preparation Manufacturing (325412)
akta.pro industry
PRIMARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAG
Sleep, Stress & Mood Support
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • OTC headache relief
  • Migraine medication
  • Pain reliever caplets
  • Consumer healthcare
  • Combination analgesic

Where Excedrin is headquartered

Location

Headquarters

HQ city
Warren
HQ country
United States
HQ region
North America

Markets served

Excedrin business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel

Revenue model

  1. OTC Consumer Health Product Sales: Excedrin generates revenue through the sale of over-the-counter headache and migraine relief medications. Products are sold as one-time purchases through retail pharmacies, mass retailers, and e-commerce channels. Revenue is transactional rather than recurring, with typical consumer purchase patterns of occasional use for headache relief.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Excedrin product offering

Product offering

Core offering

Excedrin manufactures and sells a family of over-the-counter headache and migraine relief medications combining acetaminophen, aspirin, and caffeine. The product line includes Extra Strength, Migraine, Tension Headache, PM Headache, and Rapid Relief variants sold to U.S. consumers through retail pharmacies, drug stores, mass merchants, and e-commerce channels without a prescription.

Product overview

Excedrin is a family of over-the-counter headache and migraine relief products manufactured by Haleon (formerly part of GlaxoSmithKline). The product line includes Excedrin Extra Strength (the original multi-ingredient formulation from 1960), Excedrin Migraine (FDA-approved and #1 neurologist recommended, introduced 1998), Excedrin PM (nighttime formula with sleep aid, introduced 1969), Excedrin Tension Headache, and the newer Excedrin Rapid Relief featuring patented fast-release technology. All products combine acetaminophen, aspirin, and caffeine for dual-action pain relief that works faster than ibuprofen for head pain.

Differentiator

Problem solved

Functional benefit

Brands

  • Excedrin Extra Strength: Over-the-counter headache relief caplets for minor aches and pain
  • Excedrin Migraine
  • Excedrin Tension Headache
  • Excedrin PM Headache
  • Excedrin Rapid Relief

Products and services

  • Excedrin Extra Strength Over-the-counter headache relief caplets containing acetaminophen, aspirin, and caffeine; the first multi-ingredient headache treatment product on the market, introduced in 1960.
  • Excedrin Migraine FDA-approved over-the-counter migraine treatment containing acetaminophen, aspirin, and caffeine; the #1 neurologist-recommended OTC migraine medicine and the first migraine medication available without a prescription, introduced in 1998.
  • Excedrin PM Headache Nighttime headache relief combining effective pain relievers with a sleep aid; the first combination head pain and sleep aid product, introduced in 1969.
  • Excedrin Tension Headache Over-the-counter tension headache relief product designed to temporarily relieve minor aches and pain due to headache and muscular aches.
  • Excedrin Rapid Relief OTC headache product featuring patented fast-release technology that delivers pain relief starting in 15 minutes; targets tough head pain with quick onset.

Quantifiable outcome

  • Excedrin Rapid Relief starts working in 15 minutes
  • +2 more outcomes

Companies that use Excedrin

Customer profile

Segments3 records

Ideal customer profiles3 records

Excedrin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Excedrin partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Excedrin competitors and assessment

Company assessment

Emerging players

  • Nurtec ODT: Pfizer/Biohaven's prescription CGRP migraine drug now also available OTC for acute migraine. Represents the prescription-to-OTC shift that could either complement or cannibalize Excedrin Migraine depending on regulatory and pricing outcomes.
  • Midol: Bayer's OTC brand for menstrual and hormonal-related pain, including menstrual migraines. Midol overlaps with Excedrin's 'women's hormonal migraine' customer segment, addressing the same 3-in-4 female migraine-sufferer persona.

Direct peers

  • Advil: Haleon's sister ibuprofen brand and a direct OTC pain reliever competitor. Despite the shared Haleon parent, Advil competes head-to-head with Excedrin on the same retail shelves for the same headache and pain use cases.
  • BC Powder: OTC headache powder brand (Chattem/Sanofi) historically positioned for fast headache relief. BC Powder is a direct competitor to Excedrin in the speed-of-onset OTC segment.
  • Aleve: Bayer's naproxen-based OTC pain reliever. Aleve competes directly with Excedrin on long-lasting headache relief, offering a 12-hour dosing alternative to Excedrin's short-acting combination formula.
  • Tylenol: Johnson & Johnson's flagship OTC analgesic brand. Tylenol is Excedrin's most direct competitor in OTC headache and pain relief, targeting the same consumer segments with acetaminophen-based formulations.
  • Anacin: OTC analgesic combining aspirin and caffeine — a formula very close to Excedrin's core combination. Anacin competes directly with Excedrin Extra Strength in the same combination-analgesic sub-category.
  • Motrin: Johnson & Johnson's ibuprofen-based OTC pain brand. Motrin is a direct substitute for Excedrin's Extra Strength and Tension Headache SKUs, competing on speed of relief claims.
  • Goody's Powder: Chattem/Sanofi's OTC headache powder containing acetaminophen, aspirin, and caffeine — a formula identical to Excedrin Extra Strength. Direct head-to-head competitor in the combination-analgesic segment.

Broad incumbents

  • Bayer Aspirin: Bayer's flagship OTC pain reliever and a 100+ year heritage brand. Bayer Aspirin competes with Excedrin on the aspirin-based portion of Excedrin's combination formula and shares headache-relief shelf space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Excedrin social profiles

Digital presence

Excedrin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Excedrin leadership team

Management profile

Number of profiles

Excedrin funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Excedrin M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Excedrin

What does Excedrin do?

Excedrin manufactures and sells a family of over-the-counter headache and migraine relief medications combining acetaminophen, aspirin, and caffeine. The product line includes Extra Strength, Migraine, Tension Headache, PM Headache, and Rapid Relief variants sold to U.S. consumers through retail pharmacies, drug stores, mass merchants, and e-commerce channels without a prescription.

Is Excedrin a public or private company?

Excedrin is a private company. It is classified as corporate owned and is currently operating.

When was Excedrin founded?

Excedrin was founded in 1960. It employs 11 to 50 people.

Where is Excedrin based?

Excedrin is headquartered in Warren, United States, in the North America region.

How does Excedrin make money?

One revenue line is on record: OTC Consumer Health Product Sales.

Who are Excedrin's main competitors?

Emerging players on record are Nurtec ODT and Midol. Direct peers are Advil, BC Powder, Aleve, Tylenol, Anacin, Motrin and Goody's Powder. Bayer Aspirin is listed as a broad incumbent.

Does Excedrin have an API?

No public API is recorded for Excedrin.

What industry is Excedrin in?

Excedrin's product category is OTC Headache and Migraine Medication. Its primary akta.pro industry code is CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief), with a secondary code of HLAIADAG, Sleep, Stress & Mood Support. Its NAICS code is 325412.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsExcedrin Revives Nostalgia with a Digital Pet Experience to Combat HeadachesExcedrin launched My Little Headache, a digital pet experience that mimics the escalating discomfort of a headache. The campaign promotes Excedrin Rapid Relief, an aspirin- and caffeine-free formula with patented Fast Release Technology for relief in as little as 15 minutes. It also features singer Jesse McCartney as an ambassador.YahooOnly Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't IgnoreExcedrin launched My Little Headache, a digital pet experience inspired by late-90s/early-2000s handheld virtual pets, to promote its Rapid Relief product. The product uses patented Fast Release Technology to provide pain relief in as little as 15 minutes, in an aspirin-free and caffeine-free formula.PR NewswireOnly Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't IgnoreExcedrin announced My Little Headache, a digital pet experience, and introduced Excedrin Rapid Relief. The product uses patented Fast Release Technology to provide pain relief in as little as 15 minutes, in an aspirin-free and caffeine-free formula.MediaPostIn First-Ever Brand Extension, Excedrin Launches Heady SupplementsHaleon's Excedrin launched its first supplement line, Head Care, with three products targeting headache prevention. The line includes Proactive Health and two drink mixes, supported by a content campaign. A survey cited showed 90% of sufferers want holistic management, though only 46% use proactive measures.PR NewswireExcedrin Calls on Migraine Sufferers to Share Their Personal #MYgraine ExperiencesExcedrin, a GSK Consumer Healthcare brand, has launched #MYgraine, a social media movement encouraging migraine sufferers to share their personal experiences through visual expression to raise awareness about the condition. The initiative addresses the "Migraine Diagnosis Gap," with research showing an average of six years between first migraine occurrence and formal diagnosis among the more than 39 million migraine sufferers in the US. Excedrin is partnering with artists to visually represent their own migraine experiences, aiming to help undiagnosed individuals recognize symptoms earlier and seek proper medical diagnosis.PR NewswireGamers Who Play Through Headaches Perform Poorly, New Research ShowsGSK Consumer Healthcare's Excedrin brand released new research showing that 83% of gamers who experience headaches while gaming have had to stop playing due to their symptoms, with 71% concerned about gaming-related headaches and 92% reporting increased gaming time during the COVID-19 pandemic. Excedrin has partnered with professional gamer Nadeshot (Founder & CEO of 100 Thieves) to promote a six-step mindfulness routine designed to help gamers manage headache triggers and improve focus during gameplay.PR NewswireHeadaches Associated With Commuting, Dating And Even Adulting? Now, There's An Excedrin® For ThatExcedrin is launching three limited-edition pain reliever variants—Commuter Edition, Bad Date Edition, and Adulting Edition—to address specific headache triggers. The campaign, part of the 'We See Your Pain' initiative, features partnerships with celebrities Antoni Porowski and Tan France to highlight consumer experiences with head pain.PR NewswireExcedrin® Helps Cleveland Fans Deal With Headache From 0-16 "Perfect Season"Excedrin, owned by GSK Consumer Healthcare, sponsored the 'Perfect Season Parade' in Cleveland to support fans of the Cleveland Browns during their 0-16 season. The brand provided a $7,683 donation and positioned its headache relief products as a solution for the emotional pain associated with the team's historic losing streak. The event was organized by fan Chris McNeil and took place on January 6th.PR NewswireExcedrin® Unveils "The Migraine Experience" - World's First Augmented Reality Migraine Simulator Designed To Foster Empathy For Migraine SufferersExcedrin® launched The Migraine Experience, an augmented reality migraine simulator, on April 6, 2016, in Warren, N.J. The simulator aims to help non-sufferers understand the debilitating symptoms of migraines, which affect 36 million people in the U.S., by allowing them to experience related symptoms safely. Through this initiative, Excedrin® seeks to foster empathy and understanding between migraine sufferers and their loved ones.